Molecular targets for cancer therapy.
D002051:Burkitt Lymphoma / Q000235:genetics / Q000628:therapy*; D002898:Chromosomes, Human, Pair 8; D004273:DNA, Neoplasm / Q000187:drug effects / Q000235:genetics; D006801:Humans; D007438:Introns / Q000187:drug effects; D009841:Oligonucleotides / Q000494:pharmacology*; D016376:Oligonucleotides, Antisense; D011518:Proto-Oncogene Proteins / Q000037:antagonists & inhibitors* / Q000235:genetics; D016271:Proto-Oncogene Proteins c-myc; D012323:RNA Processing, Post-Transcriptional / Q000187:drug effects*; D012333:RNA, Messenger / Q000187:drug effects
D004273:DNA, Neoplasm; D009841:Oligonucleotides; D016376:Oligonucleotides, Antisense; D011518:Proto-Oncogene Proteins; D016271:Proto-Oncogene Proteins c-myc; D012333:RNA, Messenger